Pharmacists could prescribe home-use medical devices

Summary#

HB 3499 would amend Missouri law by replacing section 338.012 and adding section 338.206. Its stated subject is pharmacists’ duties; it does not state a broader goal or promise a particular result. The bill is introduced and is not law. The current version of the parent law was not supplied, so I could not verify the changes against current law.

  • Pharmacists with a certificate of medication therapeutic plan authority may provide medication therapy services for influenza, group A streptococcus, and COVID-19 under rules jointly made by the state pharmacy and healing-arts boards. The bill replaces the current section’s reference to a statewide standing order.
  • Pharmacists may prescribe medical devices that the two boards authorize by rule. The devices must meet the bill’s definition, including being FDA Class I or II devices primarily used for a medical purpose and appropriate for home use.
  • The boards must jointly make rules for both sections. For the medical-device rules, the bill sets a deadline of six months after the act takes effect.
  • The bill does not itself require pharmacists to provide these services or prescribe devices, and it does not set out a patient application or approval process.

What it means for you#

  • Pharmacists: The bill would allow pharmacists with the specified certificate to provide the listed medication therapy services under joint-board rules. It would also allow pharmacists to prescribe medical devices authorized by rule; this section does not state a certificate requirement for that authority.
  • Patients: The bill could allow pharmacists to provide these services or prescribe authorized devices, but it does not require any pharmacist to do so or guarantee that a service or device will be available.
  • State boards: The pharmacy and healing-arts boards must jointly make rules. The bill does not create a new agency.
  • Other groups: The bill does not directly change taxes, insurance coverage, or eligibility for public benefits.

Money#

No cost information is in the available material.

  • The boards must make rules, but the bill gives no estimate of the cost or staffing needed. No publicly available information.

What is unclear#

  • The bill does not specify how pharmacists qualify to provide the three medication therapy services beyond requiring the certificate named in the bill.
  • The rules will determine which medical devices pharmacists may prescribe. The bill does not list them.
  • The bill does not set out service procedures, patient safeguards, oversight, or appeal rights; some details may be addressed in the rules.
  • The medical-device rules are due within six months after the act takes effect, but the supplied text does not state when the act would take effect.
  • The bill does not explain how these authorities would interact with other existing rules or programs.

Case for#

  • A possible argument for the bill is that it gives pharmacists a route to provide specified medication therapy services without relying on the statewide standing order described in the existing section’s text.
  • Joint rules from the pharmacy and healing-arts boards could set shared requirements for these services and device prescribing.
  • Allowing pharmacists to prescribe home-use medical devices authorized by rule could give patients another way to obtain those devices.

Case against#

  • The bill leaves important details to rules, including which devices pharmacists may prescribe and the requirements for providing the listed services.
  • It sets no deadline for the rules on medication therapy services, so that authority’s practical use could depend on when those rules are made.
  • The bill requires the boards to make rules but provides no cost estimate or staffing plan.